Insights
FDA Authorizes Dual Sensing Technology from Abbott
The FDA has authorized dual glucose‑ketone sensing technology from Medtrade exhibitor Abbott.
August 27 2026Your Medicare PTAN Has Been Revoked: What Next?
The loss of a Medicare Provider Transaction Access Number (PTAN) is much more than an administrative inconvenience.
August 27 2026M&A: Searching for the Perfect Fit
While there are still relatively “clean” transactions to be had, M&A has hit a few roadblocks.
August 27 2026
AAHomecare Needs Your Input
The survey takes less than two minutes to complete and will close on August 28.
August 23 2026Resmed Appoints Lead Director
Carol Burt will succeed Ron Taylor, Resmed’s current lead director, who is not standing for reelection at the…
August 21 2026HHS Grants New Exclusionary Authority to CMS
Historically, exclusion was primarily the domain of the OIG. Going forward, CMS appears poised to play a direct…
August 21 2026DOJ and OIG Notice of Investigation: What Comes Next?
While the specific focus area(s) have shifted some—from orthotic braces to continuous glucose monitoring and others—the areas of…
August 16 2026
Rise of the Regionals / Independents
George’s Pharmacy & Medical Equipment is a thriving “independent” DME chain, but Butch Martin, executive vice president, is…
August 16 20262Q Sales Up at Medline
Net sales for the second quarter at Medtrade exhibitor Medline Inc. hit $7.7 billion, an increase of 11.6%.
August 16 2026